XML 26 R15.htm IDEA: XBRL DOCUMENT v3.21.1
Note 8 - Capital Stock and Stock-based Compensation
3 Months Ended
Mar. 31, 2021
Notes to Financial Statements  
Shareholders' Equity and Share-based Payments [Text Block]

8.

Capital Stock and Stock-Based Compensation

 

Stock-Based Payment Awards

 

Activity under the Company’s 2000 Stock Option and Incentive Plan, as Amended, for the three months ended March 31, 2021 was as follows:

 

  

Stock Options

  

Restricted Stock Units

  

Market Condition RSU's

 
      

Weighted

                 
  

Stock

  

Average

  

Restricted

      

Market

     
  

Options

  

Exercise

  

Stock Units

  

Grant Date

  

Condition RSU's

  

Grant Date

 
  

Outstanding

  

Price

  

Outstanding

  

Fair Value

  

Outstanding

  

Fair Value

 

Balance at December 31, 2020

  2,637,339  $3.51   1,560,461  $2.44   813,031  $2.12 

Granted

  -   -   714,793   4.39   293,509   4.61 

Exercised

  (310,169)  4.01   -   -   -   - 

Vested (RSUs)

  -   -   (340,395)  2.73   -   - 

Cancelled/Forfeited

  (474,309)  4.64   (11,000)  4.17   -   - 

Balance at March 31, 2021

  1,852,861  $3.14   1,923,859  $3.10   1,106,540  $2.78 

 

Stock-based compensation expense related to stock options, restricted stock units, Market Condition RSU’s and the ESPP for the three months ended March 31, 2021 and 2020 was allocated as follows:

 

  

Three Months Ended March 31,

 

(in thousands)

 

2021

  

2020

 

Cost of revenues

 $20  $10 

Sales and marketing expenses

  93   51 

General and administrative expenses

  834   696 

Research and development expenses

  21   36 

Total stock-based compensation expenses

 $968  $793 

 

As of March 31, 2021, the total compensation costs related to unvested awards not yet recognized is $7.8 million and the weighted average period over which it is expected to be recognized is approximately 2.4 years. The Company did not capitalize any stock-based compensation.

 

The weighted average estimated fair value of the Market Condition RSUs that were granted during the three months ended March 31, 2021 was $4.61. The following assumptions were used to estimate the fair value of the Market Condition RSUs granted during the three months ended March 31, 2021 using a Monte-Carlo valuation simulation:

 

  

2021

 

Volatility

  65.1

%

Risk-free interest rate

  0.3

%

Correlation coefficient

  35.7

%

Dividend yield

  -

%

 

Earnings (Loss) Per Share

 

Basic earnings (loss) per share is calculated by dividing net income (loss) by the number of weighted average shares of common stock outstanding during the period. The calculation of diluted earnings per share assumes conversion of stock options, restricted stock units and Market Condition RSUs into common stock using the treasury method. The weighted average number of shares used to compute basic and diluted earnings per share consists of the following:

 

  

Three Months Ended March 31, 2021

 
  

2021

  

2020

 

Basic

  39,787,281   38,328,791 

Dilutive effect of equity awards

  -   - 

Diluted

  39,787,281   38,328,791 

 

The Company has excluded from the shares used in calculating the diluted earnings per common share options, restricted stock units and Market Condition RSUs totaling 4,883,260 and 4,222,425, as of March 31, 2021 and 2020 respectively, as the impact of these shares would be anti-dilutive.